Shopping Cart
Remove All
Your shopping cart is currently empty
NCL1, a phenylcyclopropylamine (PCPA)-based Lysine-specific demethylase 1 (LSD1) inhibitor, selectively inhibits LSD1 over LSD2, with IC50 values of 2.5 μM for LSD1 and 26 μM for LSD2 [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | NCL1, a phenylcyclopropylamine (PCPA)-based Lysine-specific demethylase 1 (LSD1) inhibitor, selectively inhibits LSD1 over LSD2, with IC50 values of 2.5 μM for LSD1 and 26 μM for LSD2 [1]. |
| Targets&IC50 | LSD1:2.5 ± 0.5 μM |
| Molecular Weight | 443.54 |
| Formula | C27H29N3O3 |
| Cas No. | 1196119-03-5 |
| Smiles | NC1C(C2=CC(OCC[C@H](NC(=O)C3=CC=CC=C3)C(NCC4=CC=CC=C4)=O)=CC=C2)C1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.